NVAX icon

Novavax (NVAX)

NASDAQ

$8.33

$0.18 (

+2.21%

)

1D
5D
1M
6M
1Y
5Y
Pre market

NVAX: $8.33 / ₿ 0.0001 BTC / 12124 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$8.15
$5.01 - $11.97
$1.36B
-0.78
$6,571.58
162.94M
3.16
$8.25 - $8.34
Yes

What is Novavax (NVAX)?

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

The Novavax (NVAX) stock price has been rising

The Novavax, Inc. Common Stock (NVAX) stock pre-market price today is $8.33, reflecting a +2.21% pre-market move since the market last closed. The company’s market capitalization stands at $1.36B, with a daily trading volume of $6.57K shares. The previous closing price was $8.15.

Get started with Novavax (NVAX)

Ready to get started? Follow the steps below, or read our guide on how to buy Novavax stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy NVAX

Search for NVAX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy NVAX.

NVAX FAQs

NVAX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

NVAX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Novavax, Inc. Common Stock (NVAX) has traded between a low of $5.01 and a high of $11.97.

NVAX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Novavax? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
NVAX icon
NVAX

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Novavax in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.